Company Profile
ABOUT JINYU
-
JINYU BIO-TECHNOLOGY
Founded in 1993 and public listed on the Shanghai Stock Exchange in 1999
- Top 1 FMD vaccine producer and supplier in China
- 10 billion mL FMD vaccines in past ten years
- 3 Chinese national laboratories
- 4 species cover-swine, ruminant, avian and companion animal
- 5 subsidiaries focusing on animal health industry
- 110 kinds of animal vaccines and diagnostic products
JINYU BIO-TECHNOLOGY INDUSTRIAL PARK
In 2015, Jinyu started investing in the construction of Jinyu International Biotechnology Industrial Park in Inner Mongolia, China. In 2019, the Park was put into operation, achieving intelligent manufacturing of animal vaccines for the first time in the industry.
The industrial park covers an area of 450,000 square meters under the investment of 386 million dollar, with three Chinese national laboratories, seven animal vaccine intelligent manufacturing lines and two diagnostic reagent production lines.
Through the deep integration of the Internet, big data and artificial intelligence with manufacturing technology, we achieved the acceleration on the upgrading of equipment, technology and product quality.
Corporate Culture
-
Our Vision
For Health and Better Life
-
Our Mission
From animal safety to human health
-
Our Beliefs
We are responsible to our customers.
We are responsible to our employees.
We are responsible to the company and shareholders.
We are responsible to the whole society.
-
Our Core Values
Honesty, Sense of Responsibility, and Value Orientation; Innovation, Self-examination, and Cooperation for Mutual Benefit. Create value for customers and create the future with strivers. Set goals, work together, persevere, and accomplish the mission.